| Model Number |
353101 |
| Medical Device Problem Code |
Adverse Event Without Identified Device or Use Problem (2993)
|
| Health Effect - Clinical Codes |
Hematoma (1884); Hemorrhage/Blood Loss/Bleeding (1888); Thrombosis/Thrombus (4440); No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
04/10/2024
|
|
Type of Reportable Event
|
Serious Injury
|
|
Event or Problem Description
|
|
Information was received from a manufacturer representative regarding a trial patient (pt) who was using an external neurostimulator (ens) for urge incontinence and fecal incontinence.It was reported their trial began on (b)(6) 2024.It was reported that the patient was experiencing bleeding/hemorrhage.It was noted that the patient's daughter reported that the procedure didn't go well, and patient was experiencing blood clots in their rectum and bleeding in their abdomen.Patient has been given three pints of blood and the device will be removed.Additional information was received from a manufacturer representative (rep).The rep reported that the patient developed a hematoma measuring 6 x 12 cm at the left anterior sacrum right after having the ins basic eval surgery.The caller reported surgery being on the afternoon of wednesday (b)(6) 2024, and pt went in to the er that same evening.Caller reported pt is still currently hospitalized.Caller stated hematoma could possibly have developed from the needle being inserted too deep.
|
| |
|
Additional Manufacturer Narrative
|
|
Continuation of d10: product id 306001.Product type screening device section d information references the main component of the system.Other relevant device(s) are: product id: 306001.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Additional Manufacturer Narrative
|
|
Continuation of d10: product id 306001 lot# unknown serial# implanted: (b)(6) 2024 explanted: product type screening device medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Event or Problem Description
|
|
2024-dec-09 lfc (hcp): additional information was received from the health care professional (hcp).The hcp confirmed that there was no difficulties encountered with the trial procedure.The patient was not on blood thinners prior to the procedure.The patient was previously diagnosed with clotting disorder and was permanently on medication.The hcp confirmed that the patient was provided treatment with conservative antibiotics.When asked about the current status of the patient, the hcp stated that the patient was currently doing antibiotics and followed by ct scans.
|
| |
|
Search Alerts/Recalls
|